Amyotrophic Lateral Sclerosis Therapeutics Market Size, Share & Industry Analysis, By Drug Type (Tofersen, Edaravone, Riluzole, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI110139

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 11.3% from 2024-2032
Unit	Value (USD Billion)
Segmentation	By Drug Type Tofersen Edaravone Riluzole Others
	By Route of Administration Oral Parenteral
	By Distribution Channel Hospital Pharmacy Retail & Online Pharmacy
	By Region North America (by Drug Type, by Route of Administration, by Distribution Channel, and by Country) U.S. Canada Europe (by Drug Type, by Route of Administration, by Distribution Channel, and by Country/Sub-region) U.K. Germany France Spain Italy Rest of Europe Asia Pacific (by Drug Type, by Route of Administration, by Distribution Channel, and by Country/Sub-region) Japan China Australia India Rest of Asia Pacific Rest of the World (by Drug Type, by Route of Administration, and by Distribution Channel)